Successful hypofractionated whole-breast irradiation after breast-conserving surgery in a patient with a severe history of systemic lupus erythematosus: a case report on hypofractionation, prophylactic skin management, and DIBH

Background Historical concerns over radiation-induced toxicities frequently lead to the unwarranted omission of adjuvant radiotherapy (RT) in breast cancer patients with systemic lupus erythematosus (SLE). However, modern precision RT and assessments prioritizing concurrent disease activity challenge this perspective. Case presentation We present a 31-year-old woman with early-stage left-sided breast cancer (pTisN0M0) and a history of life-threatening SLE. Because her SLE was clinically confirmed to be in sustained unmedicated remission, she underwent breast-conserving surgery followed by hypofractionated whole-breast irradiation (HF-WBI). To strictly mitigate toxicity, we utilized volumetric modulated arc therapy (VMAT) integrated with deep inspiration breath-hold (DIBH) for cardioprotection. Furthermore, stringent skin dosimetric constraints were applied alongside daily prophylactic topical superoxide dismutase (SOD) to potentially minimize radiofibrosis. The patient successfully completed RT, developing only Grade 1 acute radiodermatitis. Subsequent short-term follow-up at 10 months revealed excellent cosmetic outcomes and no early signs of late tissue toxicities. Conclusion A severe SLE history should not reflexively preclude modern breast-conserving therapy. For patients with clinically quiescent SLE, integrating VMAT-based hypofractionation, DIBH, stringent skin constraints, and prophylactic SOD represents a feasible and well-tolerated therapeutic approach. However, while short-term results are encouraging, extended follow-up is necessary to definitively confirm long-term safety regarding late toxicities.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.1927872
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Successful hypofractionated whole-breast irradiation after breast-conserving surgery in a patient with a severe history of systemic lupus erythematosus: a case report on hypofractionation, prophylactic skin management, and DIBH

周勋章, Zhaoming Peng, Mengqi Yang, Xiaoliang Wu et al.
Frontiers in Oncology
Advanced Radiotherapy Techniques
article

Successful hypofractionated whole-breast irradiation after breast-conserving surgery in a patient with a severe history of systemic lupus erythematosus: a case report on hypofractionation, prophylactic skin management, and DIBH

周勋章, Zhaoming Peng, Mengqi Yang, Xiaoliang Wu, Xin Li, Bo Huang, Zhixun Zhang, Yajie Liu
article en

Abstract

Background Historical concerns over radiation-induced toxicities frequently lead to the unwarranted omission of adjuvant radiotherapy (RT) in breast cancer patients with systemic lupus erythematosus (SLE). However, modern precision RT and assessments prioritizing concurrent disease activity challenge this perspective. Case presentation We present a 31-year-old woman with early-stage left-sided breast cancer (pTisN0M0) and a history of life-threatening SLE. Because her SLE was clinically confirmed to be in sustained unmedicated remission, she underwent breast-conserving surgery followed by hypofractionated whole-breast irradiation (HF-WBI). To strictly mitigate toxicity, we utilized volumetric modulated arc therapy (VMAT) integrated with deep inspiration breath-hold (DIBH) for cardioprotection. Furthermore, stringent skin dosimetric constraints were applied alongside daily prophylactic topical superoxide dismutase (SOD) to potentially minimize radiofibrosis. The patient successfully completed RT, developing only Grade 1 acute radiodermatitis. Subsequent short-term follow-up at 10 months revealed excellent cosmetic outcomes and no early signs of late tissue toxicities. Conclusion A severe SLE history should not reflexively preclude modern breast-conserving therapy. For patients with clinically quiescent SLE, integrating VMAT-based hypofractionation, DIBH, stringent skin constraints, and prophylactic SOD represents a feasible and well-tolerated therapeutic approach. However, while short-term results are encouraging, extended follow-up is necessary to definitively confirm long-term safety regarding late toxicities.

Frontiers in OncologyVol. 16
Peking University Shenzhen Hospital (CN), Heyou Hospital (CN)
National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality
Good health and well-being
Advanced Radiotherapy Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon